secwatch.observer — SEC 8-K summary
======================================

Issuer:     MapLight Therapeutics, Inc. (MPLT)
CIK:        0001770069
Form:       8-K
Filed at:   2026-04-29T23:59:59+00:00
Accession:  0001193125-26-191566
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Two MapLight directors not standing for reelection; Babler and Cox nominated
----------------------------------------------------------------------------

- Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D. will not stand for reelection at the June 23, 2026 Annual Meeting.
- Board nominated Martin Babler and Troy Cox as Class I director nominees to replace them.
- Both departures are not due to any disagreement with the Company on operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770069/000119312526191566/0001193125-26-191566-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770069/000119312526191566/d114505d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-191566

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer